Targeted tuberculin testing and treatment of latent tuberculosis infection
Published Date:June 9, 2000
Source:MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-6):1-51.
Corporate Authors:National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination. ; American Thoracic Society ; Centers for Disease Control and Prevention (U.S.)
Prevention & Control
Antitubercular Agents/Therapeutic Use
Tuberculin Test/History/United States
Tuberculosis, Multidrug-Resistant/Drug Therapy
Tuberculosis, Multidrug-Resistant/Prevention & Control
Tuberculosis/Prevention & Control
Series:MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. SS-6
American journal of respiratory and critical care medicine ; v. 161, no. 4, pt. 2, p. 221-247
Description:"This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines. This statement is issued in recognition of the importance of these activities as an essential component of the TB Elimination Strategy promoted by the U.S. Public Health Service Advisory Council on the Elimination of Tuberculosis, and reports the deliberations of expert consultants convened by the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC). " - p.
"This report is being published with the permission of the American Thoracic Society and as a courtesy to the MMWR readership. It is an adaptation of a report published in the American Journal of Respiratory and Critical Care Medicine 2000;161:S221--S247. " - p. v
Includes bibliographical references (p. 43-51).
Supporting Files:No Additional Files
You May Also Like: